Abstract
The gating of large-conductance Ca2+-activated K+ (BKCa) channel is primarily controlled by intracellular Ca2+ and/or membrane depolarization. These channels play a role in the coupling of excitation-contraction and stimulussecretion. A variety of structurally distinct compounds may influence the activity of these channels. Squamocin, an Annonaceous acetogenin, could interact with the BKCa channel to increase the amplitude of Ca2+-activated K+ current in coronary smooth muscle cells. Its stimulatory effect is related to intracellular Ca2+ concentrations. In inside-out patches, application of ceramide to the bath suppressed the activity of BKCa channels recorded from pituitary GH3 cells and from retinal pigment epithelial cells. ICI-182,780, an estrogen receptor antagonist, was found to modulate BKCa-channel activity in cultured endothelial cells and smooth muscle cells in a mechanism unlinked to the inhibition of estrogen receptors. Caffeic acid phenethyl ester (CAPE) and its analogy, cinnamyl-3,4-dihydroxy-α-cyanocinnamate, could directly increase the activity of BKCa channels in GH3 cells. CAPE also reduced the frequency and amplitude of intracellular Ca2+ oscillations in these cells. The CAPE-stimulated activity in BKCa channels is thought to be unassociated with its inhibition of NF-kB activation. Cilostazol, an inhibitor of cyclic nucleotide phosphodiesterase, could stimulate BKCa channel-activity and reduce the firing of action currents simultaneously in GH3 cells. Therefore, the regulation by these compounds of BKCa channels may in part be responsible for their regulatory actions on cell functions.
Keywords: Large-conductance Ca2+-activated K+ (BKCa) channel, Ca2+-activated K+ current, intracellular Ca2+, BKCa channel opener, BKCa channel inhibitor
Current Topics in Medicinal Chemistry
Title: Pharmacological Roles of the Large-Conductance Calcium-Activated Potassium Channel
Volume: 6 Issue: 10
Author(s): Sheng-Nan Wu, Adonis Z Wu and Ming-Wei Lin
Affiliation:
Keywords: Large-conductance Ca2+-activated K+ (BKCa) channel, Ca2+-activated K+ current, intracellular Ca2+, BKCa channel opener, BKCa channel inhibitor
Abstract: The gating of large-conductance Ca2+-activated K+ (BKCa) channel is primarily controlled by intracellular Ca2+ and/or membrane depolarization. These channels play a role in the coupling of excitation-contraction and stimulussecretion. A variety of structurally distinct compounds may influence the activity of these channels. Squamocin, an Annonaceous acetogenin, could interact with the BKCa channel to increase the amplitude of Ca2+-activated K+ current in coronary smooth muscle cells. Its stimulatory effect is related to intracellular Ca2+ concentrations. In inside-out patches, application of ceramide to the bath suppressed the activity of BKCa channels recorded from pituitary GH3 cells and from retinal pigment epithelial cells. ICI-182,780, an estrogen receptor antagonist, was found to modulate BKCa-channel activity in cultured endothelial cells and smooth muscle cells in a mechanism unlinked to the inhibition of estrogen receptors. Caffeic acid phenethyl ester (CAPE) and its analogy, cinnamyl-3,4-dihydroxy-α-cyanocinnamate, could directly increase the activity of BKCa channels in GH3 cells. CAPE also reduced the frequency and amplitude of intracellular Ca2+ oscillations in these cells. The CAPE-stimulated activity in BKCa channels is thought to be unassociated with its inhibition of NF-kB activation. Cilostazol, an inhibitor of cyclic nucleotide phosphodiesterase, could stimulate BKCa channel-activity and reduce the firing of action currents simultaneously in GH3 cells. Therefore, the regulation by these compounds of BKCa channels may in part be responsible for their regulatory actions on cell functions.
Export Options
About this article
Cite this article as:
Wu Sheng-Nan, Wu Z Adonis and Lin Ming-Wei, Pharmacological Roles of the Large-Conductance Calcium-Activated Potassium Channel, Current Topics in Medicinal Chemistry 2006; 6 (10) . https://dx.doi.org/10.2174/156802606777323764
DOI https://dx.doi.org/10.2174/156802606777323764 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Developments in Nanomedicines for Management of Various Health Issues Via Metabolism and Physico-Chemical Properties
Current Drug Metabolism Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Current Genomics Relationship with Programmed Cell Death Ligand 1 (PD-L1) and DTI Features in Brain Metastases of Non-small Cell Lung Cancer: A Preliminary Study
Current Medical Imaging Nanoprobes for Medical Diagnosis: Current Status of Nanotechnology in Molecular Imaging
Current Nanoscience mTOR Inhibitors: Facing New Challenges Ahead
Current Medicinal Chemistry Spectrum of Radiopharmaceuticals in Nuclear Oncology
Current Cancer Drug Targets Recent Advances in Metabolomics
Current Metabolomics A Literature Review of the Recent Radiotherapy Clinical Trials in Pediatric Brain Tumors
Reviews on Recent Clinical Trials Implication of Aberrant Glycosylation in Cancer and Use of Lectin for Cancer Biomarker Discovery
Protein & Peptide Letters Novel Antitumor Strategies Using Cytokine PEDF for Prostate Cancer Therapy
Current Angiogenesis (Discontinued) Patent Selections
Recent Patents on Biomarkers Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme
Current Pharmaceutical Design Pharmacotherapeutic Potential of Garlic in Age-Related Neurological Disorders
CNS & Neurological Disorders - Drug Targets Aptamers as Targeting Delivery Devices or Anti-cancer Drugs for Fighting Tumors
Current Drug Metabolism The Use of Fas Ligand, TRAIL and Bax in Gene Therapy of Prostate Cancer
Current Gene Therapy Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo
Anti-Cancer Agents in Medicinal Chemistry Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design
Anti-Cancer Agents in Medicinal Chemistry Potential Targets for Improving Radiosensitivity of Breast Tumor-Initiating Cells
Anti-Cancer Agents in Medicinal Chemistry Anti-inflammatory Property of AMP-activated Protein Kinase
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Human Cancer Cell Line Based Approach of 1,3,4-thiadiazole and its Fused Ring: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry